Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders. The company’s technology uses optogenetics to modulate neuronal activity by targeting synaptic mechanisms. Its approach relies on endogenous cellular processes to adjust neural signaling with spatial and temporal precision. The platform is designed